You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.
XIFIN CEO WHITE ANALYZES MEDICARE 2018 FEE CUTS - The Dark Intelligence Group

XIFIN CEO WHITE ANALYZES MEDICARE 2018 FEE CUTS

As most experts predicted, CMS will cut lab test prices deep enough to hurt many labs

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

CEO SUMMARY: If the draft lab rates that CMS published Sept. 22 for the Clinical Laboratory Fee Schedule for 2018 go into effect Jan. 1 as proposed, then clinical labs will see a cut of 28% in what they get paid for the top 20 most common tests, according to a recent analysis. The rates that CMS proposed were set under the PAMA law’s requirements that CMS collect data on what private health insurers pay labs for clinical laboratory tests and an analysis by Xifin shows that the market-price data collection effort was deeply flawed.

(PDF downloadRead Full Report
No part of this article may be reproduced or posted online without permission from THE DARK REPORT. This document contains confidential copyrighted material.

Comments

Leave a Reply

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.